LBI: Unit, Neonatal Phototherapy
What it covers
A neonatal phototherapy unit is a device used to treat or prevent hyperbilirubinemia (elevated serum bilirubin level). The device consists of one or more lamps that emit a specific spectral band of light, under which an infant is placed for therapy. This generic type of device may include supports for the patient and equipment and component parts.
The identification in 21 CFR 880.5700, neonatal phototherapy unit. FDA gives LBI no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K251308 | SnugLit(TM) Wearable Phototherapy System (SNGL-01-US) | Thera B Medical Products | Jan 15, 2026 | Traditional |
| K243372 | BiliWrap | Gerium Medical, Ltd. | May 29, 2025 | Traditional |
| K210289 | Infant Phototherapy Equipment | Bistos Co., Ltd. | May 28, 2021 | Traditional |
| K200031 | Neonatal Phototherapy System | Avalon Biomedical (Shenzhen) Limited | Oct 5, 2020 | Traditional |
| K190899 | bili-hut | Little Sparrows Technologies, Inc. | Sep 5, 2019 | Traditional |
| K182178 | neoBLUE blanket LED Phototherapy System | Natus Medical Incorporated | Dec 13, 2018 | Traditional |
| K172656 | BiliLux | Draeger Medical Systems, Inc. | May 1, 2018 | Traditional |
| K170585 | Skylife | Neolight, LLC | Oct 27, 2017 | Traditional |
| K163526 | Bilicocoon Phototherapy System | Neomedlight | Oct 6, 2017 | Traditional |
| K160745 | neoBLUE compact LED Phototherapy System | Natus Medical Incorporated | Dec 12, 2016 | Traditional |
Clearances by year
22 LBI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 262 |
| 2025 | 1 | 211 |
| 2021 | 1 | 115 |
| 2020 | 1 | 272 |
| 2019 | 1 | 150 |
| 2018 | 2 | 180 |
| 2017 | 2 | 268 |
| 2016 | 3 | 134 |
| 2015 | 1 | 212 |
| 2014 | 1 | 300 |
| 2012 | 5 | 108 |
| 2011 | 3 | 157 |
Who submits
17 applicants cleared a LBI device since 2011. 82% of the clearances went to applicants in United States, then China (5%), France (5%) and Israel (5%). By type: Traditional 95% and Abbreviated 5%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Natus Medical Incorporated | 4 |
| Atom Medical Corporation | 2 |
| Draeger Medical Systems, Inc. | 2 |
| Avalon Biomedical (Shenzhen) Limited | 1 |
| Bio-Med USA | 1 |
| Bistos Co., Ltd. | 1 |
| Fanem Lda | 1 |
| Gerium Medical, Ltd. | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 880.5700.
Standards
21 CFR 880.5700 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LBI clearances declared.
Ask about LBI
Questions about LBI
What is FDA product code LBI?
Product code LBI, “Unit, Neonatal Phototherapy” in FDA's classification database, is a Class II device type under 21 CFR 880.5700 (neonatal phototherapy unit), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 71 clearances under LBI, 22 of them since 2011.
How many 510(k) clearances are there under LBI?
FDA’s 510(k) database listed 71 clearances under LBI as of Oct 29, 2026, 22 of them decided since 2011; the most recent decision was Jan 15, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LBI 510(k)?
For the 2 LBI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 237 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LBI clearances?
Since 2011: Natus Medical Incorporated (4), Atom Medical Corporation (2), Draeger Medical Systems, Inc. (2), Avalon Biomedical (Shenzhen) Limited (1) and Bio-Med USA (1). 17 applicants have cleared a LBI device in that time.